OrthoPediatrics Expands Pediatric Cochlear Implant Market with FDA-Cleared Robotic System
Event summary
- OrthoPediatrics' partner iotaMotion received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System, now cleared for patients aged four and older.
- The robotic-assisted system is the first and only FDA-authorized open platform technology designed to standardize cochlear implant electrode array insertion.
- Cincinnati Children’s Hospital has become the first dedicated pediatric center to adopt the iotaSOFT Insertion System.
- Over 35 leading cochlear implant centers in the U.S., including nearly half of neurotology fellowship training programs, have adopted this technology.
The big picture
OrthoPediatrics is leveraging its pediatric orthopedic expertise to expand into the ENT space, aligning with broader industry trends toward digital health and advanced technology solutions. The strategic partnership with iotaMotion supports OrthoPediatrics' long-term vision of deepening its impact across the pediatric care continuum while maintaining a diversified revenue stream.
What we're watching
- Market Penetration
- The pace at which the iotaSOFT system will be adopted by additional pediatric centers and neurotology training programs.
- Revenue Diversification
- Whether OrthoPediatrics can sustain its capital-light, cash-friendly business model while expanding into adjacent areas of pediatric care.
- Technological Integration
- How the integration of robotic-assisted technology will affect clinical outcomes and operational efficiency in cochlear implant surgeries.